Alphabet's DeepMind uses A.I. to detect signs of eye disease

Machine-learning technology has been used to identify signs of eye disease and recommend how patients should be referred for treatment. The breakthrough is the result of a partnership between researchers at London's Moorfields Eye Hospital NHS Foundation Trust, DeepMind Health and the University College London Institute of Ophthalmology. The collaboration is looking at whether artificial intelligence (AI) technology can aid clinicians when it comes to improving care for patients. Founded in 2010, DeepMind was acquired by Google in 2014 and is now part of the Alphabet Group. Based in London, it undertakes research in AI.